As CHIP-dependent degradation of newly synthesized CFTR occurs in the ER, through ERAD, we asked whether a similar process accounts for CHIP-dependent degradation of newly synthesized ErbB2 in ErbB2-overexpressing breast cancer cells. The gene discussed is ERBB2; the disease is breast carcinoma.